Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain
Sponsor: McMaster University • ClinicalTrials.gov ID: NCT06081101
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.
Interventions
-
Methylprednisolone Injection
(Drug)
Medication will be injected into SI joint under ultrasound guidance
-
Ketorolac Injection
(Drug)
Medication will be injected into SI joint under ultrasound guidance
Eligibility criteria
Conditions
Locations
- Michael G. DeGroote Pain Clinic — Hamilton, Ontario, Canada
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record